Occurrence of extended-spectrum betalactamases (ESBL) in Dutch hospitals.

[1]  J. Pitout,et al.  β-Lactamases Responsible for Resistance to Expanded-Spectrum Cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis Isolates Recovered in South Africa , 1998, Antimicrobial Agents and Chemotherapy.

[2]  P. Coudron,et al.  Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find , 1997, Journal of clinical microbiology.

[3]  H. Goossens,et al.  Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital , 1997, Journal of clinical microbiology.

[4]  D. Livermore,et al.  Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. , 1996, The Journal of antimicrobial chemotherapy.

[5]  G. Jacoby,et al.  Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli , 1996, Journal of clinical microbiology.

[6]  I. Stemplinger,et al.  Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta- lactamase: parallel outbreaks due to multiple plasmid transfer , 1996, Journal of clinical microbiology.

[7]  D. Livermore.  beta-Lactamases in laboratory and clinical resistance , 1995, Clinical microbiology reviews.

[8]  D. Sirot.  Extended-spectrum plasmid-mediated β-lactamases , 1995 .

[9]  K. Bush,et al.  SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients , 1995, Antimicrobial agents and chemotherapy.

[10]  L. Sutton,et al.  Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases , 1994, Journal of clinical microbiology.

[11]  A. Philippon,et al.  Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. , 1990, The Journal of antimicrobial chemotherapy.

[12]  G. Jacoby,et al.  Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases , 1990, Antimicrobial Agents and Chemotherapy.

[13]  J. Vliegenthart,et al.  Identification of three genes coding for aminoglycoside-modifying enzymes by means of the polymerase chain reaction. , 1990, The Journal of antimicrobial chemotherapy.

[14]  S. Cole,et al.  Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae , 1989, Antimicrobial Agents and Chemotherapy.

[15]  V. Jarlier,et al.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. , 1988, Reviews of infectious diseases.

[16]  A. Harris,et al.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases. , 1975, Journal of general microbiology.

[17]  K. Thomson,et al.  Novel plasmid-mediated beta-lactamases in enterobacteriaceae: emerging problems for new beta-lactam antibiotics. , 1996, Current clinical topics in infectious diseases.

[18]  P. Attwood,et al.  Characterization of an SHV‐5 related extended broad‐spectrum beta‐lactamase in enterobacteriaceae from western australia , 1993, Pathology.